STOCK TITAN
  1. Home
  2. News
  3. PBH

Prestige Consumer Healthcare Inc - PBH STOCK NEWS

Welcome to our dedicated news page for Prestige Consumer Healthcare (Ticker: PBH), a resource for investors and traders seeking the latest updates and insights on Prestige Consumer Healthcare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Prestige Consumer Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Prestige Consumer Healthcare's position in the market.

News
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (PBH) is set to release its fiscal 2024 fourth quarter and year-end earnings results on May 14, 2024. A conference call to discuss the results will be held on May 15th, at 8:30 a.m. ET. Investors can access the webcast and replay on the Investor Relations page of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
earnings
-
News
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
Rhea-AI Summary
Dramamine®, a Prestige Consumer Healthcare brand, commemorates the joint anniversary of the barf bag and Dramamine® by launching 'The Last Barf Bag' campaign. The campaign aims to revive the cultural significance of barf bags through a documentary, upcycled bag collection, and a wearable art piece. Dramamine® celebrates its success in motion sickness relief while acknowledging the fading use of barf bags.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
-
News
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (NYSE:PBH) reported a revenue of $282.7 million in Q3, up 2.6% versus the prior year, with a diluted EPS of $1.06, up 2.2% versus the prior year. The company raised its full-year fiscal 2024 earnings outlook to approximately $4.33, and reduced its leverage ratio to 2.9x at quarter end. The revenue growth was driven by strong performance in the Eye & Ear Care category in North America and the Hydralyte® brand in the International segment. The company's net cash provided by operating activities and non-GAAP free cash flow increased significantly in Q3 and the first nine months of fiscal 2024. The North American OTC Healthcare segment revenues were flat, while the International OTC Healthcare segment revenues increased by approximately 10% in Q3 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.36%
Tags
earnings
News
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
Rhea-AI Summary
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company, has announced a voluntary recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to elevated levels of benzene found in two lots of the product. Benzene is classified as a human carcinogen, and exposure to it can result in life-threatening conditions. The recall affects specific lot codes of the product, and consumers are advised to stop using the product immediately and contact the company for a full refund. No serious adverse events have been reported to date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
-
News
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (PBH) will release its fiscal 2024 third quarter earnings on February 8, 2024. The company will host a conference call to discuss the results at 8:30 a.m. ET. The live webcast and phone participation details are available on the Investor Relations page of www.prestigeconsumerhealthcare.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.51%
Tags
earnings
-
News
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
Rhea-AI Summary
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (ticker symbol not provided), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray due to low levels of benzene in the propellant, posing a potential risk of cancer. No serious adverse events have been reported related to this recall.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
News
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Rhea-AI Summary
Insight Pharmaceuticals (Prestige Consumer Healthcare Inc.) is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder due to elevated levels of benzene in the propellant. Benzene is a human carcinogen. The affected lots were distributed nationwide in the United States through a limited number of retailers and online. Consumers can contact the company for a full refund and should stop using the product immediately if they have the affected lot codes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
-
News
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
Rhea-AI Summary
Prestige Consumer Healthcare Inc. reported revenue of $286.3 million in Q2, a decrease of 0.7% compared to the prior year. Diluted EPS was $1.07, up 5.4% from the prior year. The company reduced its leverage ratio to 3.0x. The full-year outlook for fiscal 2024 remains unchanged.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
earnings
-
News
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
Rhea-AI Summary
Prestige Consumer Healthcare Inc. to release fiscal 2024 Q2 earnings on November 2, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
earnings
News
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
Rhea-AI Summary
Prestige Consumer Healthcare to present at Barclays Global Consumer Staples Conference on September 7, 2023 at 3:00 p.m. ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
Stock PBH logo
Prestige Consumer Healthcare Inc

NYSE:PBH

PBH Rankings

#1425 Ranked by Market Cap
#1397 Ranked by Stock Gains
N/A Ranked by Dividends

PBH Stock Data

3.39B
49.30M
1.21%
105.33%
3.49%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Tarrytown

About PBH

at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th